热门资讯> 正文
Exact Sciences宣布债务交换交易
2024-04-12 03:05
- Exact Sciences (NASDAQ:EXAS) said it entered into privately negotiated exchange and purchase agreements with certain holders of the company’s 0.3750% convertible senior notes due 2028.
- As part of the agreement, the company has agreed to issue to the holders $620.7 million aggregate principal amount of a new series of 1.75% convertible senior Notes due 2031.
- The new series will be in exchange for the retirement of $359.7 million aggregate principal amount of the holders’ existing notes, and payment to the company of ~$266.8 million in cash.
- The new notes will mature on April 15, 2031, and will bear interest at a rate of 1.75% per year, payable semi-annually in arrears on October 15 and April 15 of each year, beginning on October 15, 2024.
- The conversion rate for the new notes is initially 10.0644 shares per $1,000 principal amount of New Notes.
More on Exact Sciences
- Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau
- Exact Sciences gains after data for novel cancer screening test
- Exact Sciences GAAP EPS of -$0.27 beats by $0.21, revenue of $647M beats by $7.3M
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
